Short answer
ARDELYX, INC. (ARDX) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Ardelyx announced financial results for Q2 2026, the quarter ended June 30, 2026.
ARDELYX, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Ardelyx announced financial results for Q2 2026, the quarter ended June 30, 2026
- Full results and management commentary are provided in Exhibit 99.1, the key document for investor review
Item 7.01 · Regulation FD Disclosure
- Earnings presentation scheduled for August 6, 2026 conference call
- Presentation covers financial results for quarter ended June 30, 2026
- Exhibit 99.2 provides investor materials for management’s results discussion
Item EX-99.1 · Exhibit EX-99.1
- Q2 product revenue $118.1M, up 31% YoY, with IBSRELA $86.2M and XPHOZAH $31.9M
- IBSRELA guidance cut to $350–$370M as payor utilization management pressures near-term growth
- XPHOZAH guidance maintained at $110–$120M, but long-term guidance withdrawn amid evolving market dynamics
- Cash, equivalents and investments $281.8M; $50M financing draw increases flexibility but raises long-term debt to $251.8M
- Net loss narrowed to $16.7M from $19.1M despite R&D rising to $26.1M and SG&A to $101.4M
Item EX-99.2 · Exhibit EX-99.2
- Q2 product revenue $118.1M, up 31% YoY, the company’s largest revenue quarter
- IBSRELA revenue $86.2M, up 33% YoY, but FY2026 guidance reduced to $350M-$370M from $410M-$430M
- XPHOZAH revenue $31.9M, up 27% YoY, with FY2026 guidance reiterated at $110M-$120M
- Operating expenses expected below $500M, supporting management’s path to profitability in 2027
- Cash and investments $281.8M, including a $50M debt drawdown, versus $264.7M at December 31, 2025
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ARDELYX, INC. 8-K filings
Get the next ARDX 8-K as it lands
Follow ARDX for push alerts, or ask the research agent what this filing means.